|
|
Date:14 September 2021, tuesday
Time:7:00 pm - 8:05 pm
Duration:65 minutes
VENUE:
- LIVE Webinar (online)
- Star Room, Level 42, Cordis, Hong Kong
(As a precautionary measure to prevent the spread of the coronavirus outbreak, we have a limited capacity. You are kindly requested to RSVP to reserve seats.)
If you're already registered for this webinar, please login below:
ALREADY REGISTERED?
SPEAKER:
Prof. Michel DELFORGE
Professor of Medicine, Department of Hematology,
Catholic University of Leuven, Belgium
Prof. DELFORGE is a Professor of Medicine in the Department of Hematology at the Catholic University of Leuven, Belgium. He trained in Leuven and at the University of Minnesota, USA and obtained a doctoral degree in biomedical sciences. Prof. DELFORGE is currently the chairman of the Cancer Institute Leuven and clinical head of the Department of Hematology where he directs the plasma cell dyscrasia unit. He is also a senior clinical investigator, chairman of the Belgian Myeloma Working Party: and active member of the Intergroupe Francophone du Iviyelome: HOVON (Hemato- Oncology Foundation for Adults in the Netherlands), and the International Myeloma Working Group. He holds the Luc Fraiture Chair in Hematology at the University of Leuven. and has authored or co- authored more than 100 manuscripts and several book chapters in the field of hematology.
MODERATOR:
Dr. Man Fai LAW
Specialist in Hematology and Hematological
Oncology, Hong Kong
Speakers
$-[WCSpeakerDisplayHTML]-$
|
|
Redefining the disease management of newly diagnosed multiple myeloma
Registration Is Closed
|
|
|
|
|